Table 1. Demographics of Positive Patients.
| HIV | Hepatitis B | Hepatitis C | |
|---|---|---|---|
| N (%) | N (%) | N (%) | |
| Age | |||
| New | 7 | 20 | 58 |
| Range | 23–51 | 29–78 | 18–69 |
| Median (IQR) | 29.5 (38,43.5) | 44 (34,57) | 25 (36,49) |
| Known | 90 | 23 | 373 |
| Range | 20–60 | 21–72 | 18–81 |
| Median (IQR) | 47.5 (33,44.5) | 42 (33.5,45) | 39 (34,46) |
| Gender | |||
| New | 7 | 20 | 58 |
| Male | 4 (57.1) | 16 (80) | 47 (81) |
| Female | 3 (42.9) | 4 (20) | 11 (19) |
| Known | 90 | 23 | 373 |
| Male | 57 (63.3) | 16 (69.6) | 235 (63) |
| Female | 33 (36.7) | 7 (30.4) | 138 (37) |
| Mode of Acquisition | |||
| New | 7 | 20 | 58 |
| MSMa | 3 (42.8) | 1 (5) | 0 |
| IVDUb | 1 (14.3) | 1 (5) | 37 (63.8) |
| HSc | 3 (42.8) | 0 | 2 (3.4) |
| NRId | 0 | 9 (45) | 14 (24.1) |
| Vertical/COHPe | 0 | 9 (45) | 3 (5.1) |
| Nasal DUf | 0 | 0 | 2 (3.4) |
| Known | 90 | 23 | 373 |
| IVDUb | 48 (53.3) | 5 (21.8) | 333 (89.3) |
| HSc | 12 (13.3) | 13 (56.5) | 5 (1.3) |
| Blood Transfusion | 0 | 1 (4.3) | 4 (1) |
| Anti D | 0 | 0 | 5 (1.3) |
| NRId | 0 | 2 (8.7) | 21 (5.6) |
| Nasal DUf | 0 | 0 | 1 (0.3) |
| Verticale | 0 | 1 (4.3) | 2 (0.5) |
| Haemophilia | 0 | 0 | 1 (0.3) |
| MSMa | 30 (33.3) | 1 (4.3) | 1 (0.3) |
| Active IVDU | |||
| New | 7 | 20 | 58 |
| Active IVDUb | 1 (14.3) | 1 (5) | 37 (63.8) |
| Known | 90 | 23 | 373 |
| Active IVDUb | 17 (18.8) | 0 (0) | 135 (40.5) |
| High Risk Postal Codes | |||
| New | 7 | 20 | 58 |
| Dublin area | 7 (100) | 18 (90) | 54 (93.1) |
| Known | 90 | 23 | 373 |
| Dublin area | 63 (70) | 19 (82.6) | 221 (59.2) |
| Homelessness | |||
| New | 7 | 20 | 58 |
| No fixed abode | 2 (28.5) | 1 (5) | 19 (32.7) |
| Known | 90 | 23 | 373 |
| No fixed abode | 20 (22.2) | 3 (13) | 125 (33.5) |
aMSM: Men who have sex with men
bIVDU: Intravenous drug users
cHS: Heterosexual
dNRI: No risk identified
eCOHP: Country of high prevalence
fNasal DU: Nasal drug use